CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC
Prof Richard Simcock speaks to ecancer at the SIOG 2019 meeting in Geneva about the challenges of delivering care to older adult patients with breast cancer.
Prof Simcock explains that, while some older breast cancer patients are relatively fit, some may have other comorbidities, physical frailty and other medical problems that should be taken into consideration.
The session he participated in was a multidisciplinary session on how to best evaluate and deliver the most appropriate care to these patients.
This service has been kindly supported by unrestricted grants from Janssen Oncology and Sanofi Genzyme.
CDK4/6 inhibitors and endocrine therapy in elderly female patients with advanced hormone receptor positive HER-2 negative BC
Biological ageing measures in clinical assessments can improve treatment in older women with breast cancer
Gaza's cancer patients: Navigating the dual struggle of illness and war
Cancer in emergencies: What can we do better to protect the most vulnerable?
Powering equity in cancer care through digital health
Grand Rounds: Improving quality of patient-centred care
Do patients and doctors treatment aspirations align? KCCure survey – part A
Neo-adjuvant therapy for different cancers in the Philippines
IORT at Fortis Hospital Bangalore in India